FDA Adverse Event Injury Summary report: N

COOLSCULPTING® SYSTEM

MDR report key: 16890488 · Received May 8, 2023

Report

Report Number
3007215625-2023-00599
Event Type
Injury
Date Received
May 8, 2023
Date of Event
July 15, 2022
Report Date
May 8, 2023
Manufacturer
ALLERGAN PLEASANTON
Product Code
OOK
PMA / PMN Number
K160259
Removal / Correction Number
Z-1349-2022
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION: D4, D1. H11-: CORRECTED DATA: H9.

Additional Manufacturer Narrative · 0

ACCORDING TO THE COOLSCULPTING USER MANUAL, UNDER RARE ADVERSE EVENTS, PARADOXICAL ADIPOSE HYPERPLASIA (PH/PAH) IS CHARACTERIZED BY A VISIBLY ENLARGED TISSUE VOLUME WITHIN THE TREATMENT AREA, WHICH MAY DEVELOP TWO TO FIVE MONTHS AFTER TREATMENT. SURGICAL INTERVENTION MAY BE REQUIRED. PAH IS NOT RELATED TO ANY COOLSCULPTING DEVICE FAILURE MODE BUT IT IS OBSERVED MORE FREQUENTLY WITH THE PARALLEL PLATE APPLICATORS. PAH IS INCLUDED IN THE RISK MANAGEMENT FILES OF THE DEVICE AS AN INHERENT RISK TO THE USE OF CRYOLIPOLYSIS FOR LOCALIZED FAT REDUCTION. A SUPPLEMENTAL REPORT WILL BE SUBMITTED IF AND WHEN ADDITIONAL INFORMATION IS OBTAINED. ZELTIQ INITIATED A VOLUNTARY DISCONTINUATION AND RECALL OF PARALLEL PLATE APPLICATORS FOR THE COOLSCULPTING® SYSTEM DUE TO THE OBSERVANCE OF AN INCREASED RATE OF PARADOXICAL HYPERPLASIA (PH) ASSOCIATED WITH THESE APPLICATORS DURING A RECENT ANALYSIS OF DATA FROM THE 2019-2021 TIMEFRAME. THESE APPLICATORS ARE SOLD UNDER THE BRAND NAMES COOLCORE, COOLCURVE, COOLCURVE+, COOLMAX AND COOLFIT.

Description of Event or Problem · 0

ALLERGAN AESTHETICS RECEIVED A REPORT OF A PATIENT TREATED WITH COOLSCULPTING TO THE UNDER THE CHIN, UPPER FLANK (CHEST), AND INFRA-SCAPULAR AREAS ON (B)(6) 2022 USING COOLMINI AND LEGACY COOLCURVE PLUS AND MAY HAVE DEVELOPED PARADOXICAL HYPERPLASIA (PAH/PH) AFTER TREATMENT. DIAGNOSIS BY NURSE WITHIN CEF ON (B)(6) 2023.

Description of Event or Problem · 0

ALLERGAN AESTHETICS RECEIVED A REPORT OF A PATIENT TREATED WITH COOLSCULPTING TO THE UNDER THE CHIN, UPPER FLANK (CHEST), AND INFRA-SCAPULAR AREAS ON (B)(6) 2022 USING COOLMINI AND LEGACY COOLCURVE PLUS AND MAY HAVE DEVELOPED PARADOXICAL HYPERPLASIA (PAH/PH) AFTER TREATMENT. DIAGNOSIS BY NURSE WITHIN CEF ON (B)(6) 2023.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
638963 COOLSCULPTING® SYSTEM DERMAL COOLING PACK/VACUUM/MASSAGER OOK ALLERGAN PLEASANTON NI

Patients

Seq Age Sex Outcome Treatment
1 41 YR Male Required Intervention